Practice Overview Demo Data
Wednesday, May 7, 2026
Dr. Sarah Cohen | Women's Health Associates
Flagged for Follow-up
8
Require clinician review
Active Patients
47
+5 this month
Checks This Month
23
of 47 patients checked in
Avg Symptom Burden
5.8/10
+0.3 from last month
Recent Activity
Last 5 checks
MR
M.R., Age 45
Check #4 completed. Sleep burden 8/10, cognitive scores trending below typical range.
May 6
TL
T.L., Age 51
Check #2 completed. Mood cluster improved +18% since first check.
May 5
AK
A.K., Age 43
First check completed. Urogenital and joint pain clusters flagged for review.
May 4
ND
N.D., Age 48
Check #6 completed. Wellness index stable at 71. No new flags.
May 3
RB
R.B., Age 46
Check #3 completed. Adherence dropped to 68%. Prompted follow-up.
May 2
Practice Symptom Trends
6-month view
Practice-Level Symptom Trends
Sleep | Mood | Cognitive clusters, aggregated across 47 patients
Sleep
Mood
Cognitive
Integration Status
Configure
EHR Connection
Pending Setup
FHIR R4 API
Available
SSO (SAML 2.0)
Not Configured
Notifications
Active
Quick Actions
Patient List Demo Data
47 patients enrolled
| Patient | Age | Last Check | Checks | Top Concern | Wellness Index | Status |
|---|---|---|---|---|---|---|
MR M.R.NEW DATA |
45 | May 6, 2026 | 4 | Sleep, Cognitive | 62/100 | Flagged |
TL T.L.NEW DATA |
51 | May 5, 2026 | 2 | Mood | 58/100 | Active |
AK A.K.NEW DATA |
43 | May 4, 2026 | 1 | Urogenital, MSK | 54/100 | New |
ND N.D. |
48 | May 3, 2026 | 6 | Sleep | 71/100 | Active |
RB R.B. |
46 | May 2, 2026 | 3 | Mood, Sleep | 49/100 | Flagged |
SK S.K. |
47 | Apr 28, 2026 | 4 | Cognitive, Urogenital | 62/100 | Flagged |
LG L.G. |
50 | Apr 25, 2026 | 5 | Vasomotor | 65/100 | Active |
DF D.F.NEW DATA |
44 | Apr 22, 2026 | 1 | Joint Pain, Fatigue | 56/100 | New |
YS Y.S. |
52 | Apr 20, 2026 | 8 | Sleep, Mood | 73/100 | Active |
HM H.M.NEW DATA |
39 | Apr 18, 2026 | 1 | Mood, Cognitive | 61/100 | New |
Showing 10 of 47 patients. Click any row to view full report.
DR
D.R. Demo Data
Patient Demographics
Patient ID
MRK-2026-0607
Date of Birth
1981-03-14
Sex
Female
Phone
+972-50-***-**89
Assigned Provider
Dr. Sarah Cohen
Enrollment Date
Jan 28, 2026
EHR-Ready Summary
MARKABLE Visit Prep Summary - D.R., F, 45y
Visit 19 | Date: 2026-06-07
Current Therapy: Progesterone (micronized) 200mg, daily. Started less than a month ago. Adherence: very consistent. Reported side effect: spotting.
Visit Focus: Hot flashes.
Symptom Landscape (0-10): Sugar cravings 9, Headaches/migraines 9, Hand/wrist discomfort 9, Early awakening 8, Motivation drop 8.
Bleeding Patterns: Over last 3 months, more irregular than usual, with heavier bleeding.
Functional Signals - Cognitive: Reaction time 515ms, Word retrieval 3, Working memory span 6/4, Delayed recall 3/4 (cued 4/4). Physiological (facial): Skin dryness 70 (+2), Periorbital fine lines 69 (+5), Facial redness 74 (+1).
Wellness check. Not a clinical diagnosis. Supplementary intake data.
HL7 FHIR R4 compatible. Also exportable as PDF or HL7 CDA.
Export PDF
Export CDA
Current Therapy
Patient-reported
Medication
Progesterone (micronized) 200mg
Frequency
Daily
Started
Less than a month ago
Adherence
Very consistent
Reported Side Effect
Spotting
Visit Focus
What she most wants to discuss
Hot flashes
The patient flagged this as her top priority for the visit. Leading with it can make the limited visit time count.
Symptom Landscape
Self-reported, 0-10 scale
Bleeding Patterns
Reported, last 3 months
Regularity
More irregular than usual
Flow
Heavier bleeding
Reported cycle and bleeding changes over the last 3 months. Shared here as patient-reported context, not a clinical finding.
Functional Signals - Cognitive
THINK Check
| Measure | Result |
|---|---|
| Reaction time | 515ms |
| Word retrieval | 3 |
| Working memory span | 6/4 |
| Delayed recall | 3/4 (cued 4/4) |
Functional Signals - Physiological
Facial, vs baseline
| Marker | Score | Change |
|---|---|---|
| Skin dryness | 70 | +2 |
| Periorbital fine lines | 69 | +5 |
| Facial redness | 74 | +1 |
Facial wellness markers shown as scores with change since baseline. Supplementary context only.
Visit History
Recent check-ins
Visit 16
Apr 12, 2026
Sleep
Top focus
Visit 17
May 3, 2026
Mood
Top focus
Visit 18
May 24, 2026
Cravings
Top focus
Visit 19
Jun 7, 2026
Hot flashes
Current
Suggested Discussion Points for Next Visit
- Visit focus is hot flashes. Leading with this can make the limited visit time count.
- Recently started micronized progesterone 200mg daily with very consistent adherence, and reports spotting as a side effect. May be worth setting expectations on early spotting.
- Reports more irregular and heavier bleeding over the last 3 months. May warrant a directed conversation.
- Highest reported symptoms are sugar cravings (9), headaches or migraines (9), and hand or wrist discomfort (9), alongside early awakening (8) and a drop in motivation (8).
- Functional signals show slower reaction time and lower word retrieval, with facial markers shifted since baseline. Shared as supplementary context.
These are data-driven conversation starters, not clinical recommendations. All clinical decisions remain at the provider's discretion.
Provider Notes
Internal only, not shared with patient
Last saved: Jun 7, 2026 at 14:22 by Dr. Cohen
Practice Analytics Demo Data
Aggregate data across 47 enrolled patients
Average Time to First Check
2.3 days
From invitation to first completed check
Patient Engagement Rate
78%
Patients completing checks on schedule
Most Common Symptom Cluster
Sleep
Reported as top concern by 62% of patients
Average Wellness Index
58 /100
Across all active patients
Symptom Distribution
Top reported clusters
Engagement Over Time
6-month view
Monthly Active Checks
Dec 2025 through May 2026
Sample data for demonstration purposes. MARKABLE is a wellness tool, not a medical device. All patient names, scores, and clinical data shown on this page are fictional. No real patient information is displayed. MARKABLE reports are supplementary wellness data and do not constitute clinical diagnoses.
© 2026 MARKABLE™ Ltd. All rights reserved.
© 2026 MARKABLE™ Ltd. All rights reserved.